Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
GLUCOSIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION THEREOF
Document Type and Number:
WIPO Patent Application WO/2016/074566
Kind Code:
A1
Abstract:
Disclosed are a compound represented by general formula (I), a pharmaceutically acceptable salt thereof, an easily-hydrolytic prodrug ester thereof or an isomer thereof, and a pharmaceutical composition containing the compound used as a sodium glucose co-transporter 2 inhibitor for treating or suspending diabetes mellitus, diabetic retinopathy, diabetic neuropathy, diabetic nephropathy, and insulin resistance-related diseases.

Inventors:
SHI DONGFANG (CN)
FU CHANGJIN (CN)
LIU WEI (CN)
FANG FEI (CN)
CAO CHENGPAO (CN)
ZHANG CHANGLIANG (CN)
CHENG XI (CN)
Application Number:
PCT/CN2015/093089
Publication Date:
May 19, 2016
Filing Date:
October 28, 2015
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
ATOM BIOSCIENCE AND PHARMACEUTICAL CO LTD (CN)
International Classes:
C07D421/10; A61K31/351; A61P3/00; A61P3/04; A61P3/06; A61P3/10; A61P5/50; A61P9/10; A61P9/12; A61P13/12; A61P25/00; A61P27/02
Domestic Patent References:
WO2005012326A12005-02-10
Foreign References:
CN104672227A2015-06-03
CN104817554A2015-08-05
Other References:
LI, CHUNLI ET AL.: "Progress in Preparation and Properties of Selenophene Derivatives", JOURNAL OF HENAN UNIVERSITY (NATURAL SCIENCE), vol. 43, no. 3, 31 May 2013 (2013-05-31), pages 258 - 264
MEANWELL, N.A.: "Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design", JOURNAL OF MEDICINAL CHEMISTRY, vol. 54, 17 March 2011 (2011-03-17), pages 2529 - 2591
Attorney, Agent or Firm:
NANJING TIANHUA PATENT AGENT CO., LTD. (CN)
南京天华专利代理有限责任公司 (CN)
Download PDF: